Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Odyssey Health (ODYY) Depreciation and Depletion (2017 - 2020)

Odyssey Health has reported Depreciation and Depletion over the past 4 years, most recently at $138.0 for Q3 2020.

  • For Q3 2020, Depreciation and Depletion rose 0.73% year-over-year to $138.0; the TTM value through Jul 2020 reached $552.0, changed 0.18%, while the annual FY2022 figure was $414.0, 25.0% down from the prior year.
  • Depreciation and Depletion for Q3 2020 was $138.0 at Odyssey Health, roughly flat from $138.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $138.0 in Q3 2017 and troughed at -$5814.0 in Q2 2017.
  • A 4-year average of -$287.21 and a median of $138.0 in 2017 define the central range for Depreciation and Depletion.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 102.37% in 2018 and later decreased 0.72% in 2019.
  • Year by year, Depreciation and Depletion stood at $138.0 in 2017, then changed by 0.0% to $138.0 in 2018, then changed by 0.0% to $138.0 in 2019, then changed by 0.0% to $138.0 in 2020.
  • Business Quant data shows Depreciation and Depletion for ODYY at $138.0 in Q3 2020, $138.0 in Q2 2020, and $138.0 in Q1 2020.